Compare Amylx Pharmaceuticals Inc (AMLX) vs NetApp Inc. (NTAP) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Amylx Pharmaceuticals Inc vs NetApp Inc. — how do they compare? Amylx Pharmaceuticals Inc trades at $23.96 (market cap $2.64B), while NetApp Inc. trades at $199.43 (market cap $38.95B). The key difference: NetApp Inc. is far larger — about 14.8× Amylx Pharmaceuticals Inc's market cap, and NetApp Inc. pays a 1.05% dividend while Amylx Pharmaceuticals Inc pays none. Which is the better fit depends on your goals.
| AMLX | NTAP | |
|---|---|---|
Market Cap | $2.64B | $38.95B |
Sector | Health | Technology |
52-Week High | $24.19 | $198.72 |
52-Week Low | $7.82 | $94.11 |
Enterprise Value | $2.39B | $38.10B |
Dividend Yield | — | 1.05% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Amylx Pharmaceuticals Inc
Amylyx Pharmaceuticals is a biopharmaceutical firm focused on developing therapies for rare diseases. Its pipeline includes treatments for conditions like post-bariatric hypoglycemia and congenital hyperinsulinism.
Read more on AMLX →About NetApp Inc.
NetApp is a leading provider of enterprise data management and storage solutions. The company's three operating business units are products, software maintenance, and hardware maintenance. NetApp transitioned from a data center storage firm to a company with software data management solutions for multicloud environments. The California-headquartered company sells globally and has approximately 10,000 employees.
Read more on NTAP →
